|Articles|October 13, 2016
Medpace Selects Montrium Connect EDMS
Advertisement
The Montrium Connect platform empowers Medpace to centralize and standardize clinical records
MONTREAL, QC - Cincinnati-based CRO Medpace has selected Montrium's eTMF Connect and RegDocs Connect solutions for the management of Medpace' clinical and regulatory documentation, improving clinical trial efficiency via a cloud-based document solution and enhancing their technology platform. Combined, these solutions form a comprehensive Electronic Document Management System (EDMS). "Medpace selected Montrium after evaluating several EDMS solutions available on the market. What we liked the most about the eTMF Connect & RegDocs Connect solutions, provided on the Montrium Connect platform, was the synergy between the system functionality and how we currently manage our clinical trials," said Gary Rickels, Director of IT Infrastructure & Support at Medpace. "Montrium is a well-known knowledge leader for the CRO industry, and comes with a strong reputation for providing a robust solution set and supporting implementation & validation services. The added value in built-in configurable workflows, PDF conversion capability, a true EDM and TMF model structure built in, as well as digital signature technology will give us the platform we need to continue our extensive growth. " The Montrum Connect platform provides a collaborative environment for organizations engaging in clinical activity, allowing them to manage centrally all of the clinical, regulatory and quality documentation required by the regulatory agencies. Montrium Connect can be deployed in an on-premise deployment or via Montrium's qualified GxP cloud hosted on Microsoft Azure. "Contract Research Organizations (CROs) play a critical role in clinical trials, and have emerged as integral stakeholders in the compilation of Trial Master Files and electronic submissions," said Paul Fenton, President & CEO of Montrium. "We are excited to have been selected as a strategic partner of Medpace to help them empower their continued growth. Partnering with a clinical trial powerhouse such as Medpace attests to the maturity and comprehensiveness of our growing solution set."
Additional Information
- To learn more about the Montrium Connect platform and it's suite of regulated content management applications, including eTMF Connect and RegDocs connect, visit
www.montrium.com/connect
- Stay up to date on the latest Montrium news on LinkedIn:
www.linkedin.com/company/montrium
About Montrium
Montrium is a global leader in cloud-based document & quality management solutions and GxP consulting services for the Life Sciences. Operating in the Life Sciences for over 10 years, Montrium has been successfully helping organizations implement and maintain technology to improve their business processes and increase compliance. Montrium currently serves over 7500 satisfied users in over 20 countries. For more information on the products and services Montrium provides, please visit their website:
www.montrium.com
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,300 people across 35 countries. For more information visit
www.medpace.com
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
2
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
3
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
4
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
5